Korean

Revolutionary Drug Delivery: How Nasal Nanoparticles Target Glioblastoma with Magnetic Precision

A team of Korean researchers has developed a groundbreaking drug delivery technique that administers anti-cancer nanoparticles through the nose and precisely guides them to malignant brain tumors, specifically glioblastomas, using magnetic fields. In
Revolutionary Drug Delivery: How Nasal Nanoparticles Target Glioblastoma with Magnetic Precision
CARTISTEM vs. Traditional Treatments: What Makes Medipost's Stem Cell Therapy a Game-Changer?

CARTISTEM vs. Traditional Treatments: What Makes Medipost's Stem Cell Therapy a Game-Changer?

Medipost announced on Thursday that it will begin implementing domestically produced media for the commercialization of CARTISTEM, its umbilical cord-derived allogeneic mesenchymal stem cell treatment, in Japan.Media is a crucial component that provi
Can Donanemab Expand Alzheimer's Treatment to Lewy Body Dementia? Key Insights from Korean Lilly's Latest Clinical Trials

Can Donanemab Expand Alzheimer's Treatment to Lewy Body Dementia? Key Insights from Korean Lilly's Latest Clinical Trials

Lilly, a major pharmaceutical company, has launched procedures in South Korea for a global clinical trial of its Alzheimer's treatment, Kisunla (donanemab), targeting Lewy body dementia patients. The medical community is watching closely to see if Ki
CT-P72/ABP-102: The Next Big Breakthrough in HER2 Cancer Treatment?

CT-P72/ABP-102: The Next Big Breakthrough in HER2 Cancer Treatment?

Celltrion announced on Friday that its next-generation multi-antibody drug, CT-P72/ABP-102, has demonstrated exceptional efficacy and tolerability, confirming its potential for treating various solid tumors.The company presented these findings at the
Revolutionary AI Solution by Seers Detects Abnormal Signals in Patient Monitoring: What You Need to Know

Revolutionary AI Solution by Seers Detects Abnormal Signals in Patient Monitoring: What You Need to Know

On Thursday, Seers, a leading wearable artificial intelligence (AI) diagnostics monitoring company, announced a groundbreaking achievement. Their newly developed AI solution for precisely detecting abnormal event signals in hospitalized patients' vit
How Angeliq and Other Treatments Are Transforming Menopausal Care in 2026

How Angeliq and Other Treatments Are Transforming Menopausal Care in 2026

Daewon Pharmaceutical hosted a two-day academic symposium on June 6-7, focusing on the clinical applications of its menopausal hormone therapy Angeliq and other key products, the company announced on Thursday.The event was chaired by Professor Hwang
How Hyundai BioScience's XAFTY Could Revolutionize Ebola Treatment: A Free Supply Proposal

How Hyundai BioScience's XAFTY Could Revolutionize Ebola Treatment: A Free Supply Proposal

Hyundai Bioscience announced on Thursday that its U.S. subsidiary, Hyundai Bio USA, has proposed to the World Health Organization (WHO) and local health authorities to provide their broad-spectrum antiviral candidate XAFTY (CP-COV03) free of charge t
Coronary Intravascular Lithotripsy Gains Attention as Safer Alternative for Heavily Calcified Arteries

Coronary Intravascular Lithotripsy Gains Attention as Safer Alternative for Heavily Calcified Arteries

An 83-year-old patient identified only by the surname A had hypertension and diabetes, as well as heart failure and severe mitral regurgitation caused by a previous myocardial infarction. The patient was diagnosed with severe calcified coronary arter
Huons Group Hosts Chinese Medical Delegation to Expand Healthcare and Aesthetics Collaboration

Huons Group Hosts Chinese Medical Delegation to Expand Healthcare and Aesthetics Collaboration

South Korea's Huons Group hosted a delegation of medical professionals from China's Jilin Province as part of a bilateral exchange program aimed at promoting collaboration in medical aesthetics and healthcare technologies.The company said Wednesday t
Can GLP-1 Medications Reduce Breast Cancer Risk? New Research Reveals Surprising Findings

Can GLP-1 Medications Reduce Breast Cancer Risk? New Research Reveals Surprising Findings

GLP-1 class drugs, which have taken the world by storm as obesity treatments, are now showing promising potential in the field of oncology. After demonstrating effectiveness in cardiovascular and kidney diseases, recent studies have revealed possibil

© Copyright by News1. All Rights Reserved.